ADAM9 |
A disintegrin and a metalloprotease 9 |
ArgBP2 |
Sorbin and SH3 domain-containing protein 2 |
AIPC |
Androgen-independent prostate cancer |
APP |
Amyloid-precursor-protein |
CDCP1 |
CUB domain containing protein 1 |
COPD |
Chronic obstructive pulmonary disease |
CRD |
Cone-rod dystrophy |
ECM |
Extracellular matrix |
EGF |
Epidermal growth factor |
EMCV |
Encephalomyocarditis virus |
EMT |
Epithelial-mesenchymal transition |
EphB4 |
Ephrin type-B receptor 4 |
GBM |
Glioblastoma |
HB-EGF |
Heparin-binding EGF-like growth factor |
HCC |
Hepatocellular carcinoma |
HVR |
Hyper-variable region |
MDC9 |
Metalloprotease/disintegrin/cysteine-rich protein 9 |
MGCs |
Multinucleated giant cells |
MICA |
MHC Class I polypeptide-related sequence A |
MiRNA |
microRNA |
MMP |
Matrix metalloproteinase |
Naa10p |
N-α-Acetyltransferase 10 protein |
PC |
Proprotein convertase |
PMNs |
Polymorphonuclear neutrophils |
PrPc |
Cellular prion protein |
SH3 |
Src-homology 3 |
SNX |
Sorting nexin |
TNBC |
Triple-negative breast cancer |
TNC |
Tenascin-C |
TNF-α |
Tumor necrosis factor-α |
tPA |
Tissue-type plasminogen activator |
VE-cadherin |
Vascular endothelial cadherin |